WVE Wave Life Sciences Ltd.

Nasdaq wavelifesciences.com


$ 7.81 $ -0.06 (-0.76 %)    

Friday, 17-Oct-2025 15:59:58 EDT
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 7.81
$ 7.77
$ 7.55 x 1,200
$ 8.30 x 10
$ 7.61 - $ 8.02
$ 5.28 - $ 16.74
1,761,054
na
1.24B
$ 1.26
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-30-2025 06-30-2025 10-Q
2 05-08-2025 03-31-2025 10-Q
3 03-04-2025 01-01-1970 10-K
4 11-12-2024 09-30-2024 10-Q
5 08-08-2024 06-30-2024 10-Q
6 05-10-2024 03-31-2024 10-Q
7 03-06-2024 12-31-2023 10-K
8 11-09-2023 09-30-2023 10-Q
9 08-03-2023 06-30-2023 10-Q
10 05-03-2023 03-31-2023 10-Q
11 03-23-2023 12-31-2022 10-K
12 11-10-2022 09-30-2022 10-Q
13 08-11-2022 06-30-2022 10-Q
14 05-12-2022 03-31-2022 10-Q
15 03-03-2022 12-31-2021 10-K
16 11-10-2021 09-30-2021 10-Q
17 08-05-2021 06-30-2021 10-Q
18 05-13-2021 03-31-2021 10-Q
19 03-04-2021 12-31-2020 10-K
20 11-09-2020 09-30-2020 10-Q
21 08-10-2020 06-30-2020 10-Q
22 05-11-2020 03-31-2020 10-Q
23 03-02-2020 12-31-2019 10-K
24 11-05-2019 09-30-2019 10-Q
25 08-06-2019 06-30-2019 10-Q
26 05-10-2019 03-31-2019 10-Q
27 03-01-2019 12-31-2018 10-K
28 11-09-2018 09-30-2018 10-Q
29 08-09-2018 06-30-2018 10-Q
30 05-09-2018 03-31-2018 10-Q
31 03-12-2018 12-31-2017 10-K
32 11-09-2017 09-30-2017 10-Q
33 08-09-2017 06-30-2017 10-Q
34 05-10-2017 03-31-2017 10-Q
35 03-16-2017 12-31-2016 10-K
36 11-09-2016 09-30-2016 10-Q
37 08-15-2016 06-30-2016 10-Q
38 05-16-2016 03-31-2016 10-Q
39 03-30-2016 12-31-2015 10-K
40 12-17-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 clear-street-initiates-coverage-on-wave-life-sciences-with-buy-rating-announces-price-target-of-22

Clear Street analyst Bill Maughan initiates coverage on WAVE Life Sciences (NASDAQ:WVE) with a Buy rating and announces Pric...

 wells-fargo-maintains-overweight-on-wave-life-sciences-lowers-price-target-to-18

Wells Fargo analyst Tiago Fauth maintains WAVE Life Sciences (NASDAQ:WVE) with a Overweight and lowers the price target from...

 why-is-gsk-partner-wave-life-sciences-stock-trading-lower-on-wednesday

Wave Life Sciences shares early WVE-006 trial results in alpha-1 antitrypsin deficiency, reporting durable protein production a...

 hc-wainwright--co-reiterates-buy-on-wave-life-sciences-maintains-22-price-target

HC Wainwright & Co. analyst Andrew S. Fein reiterates WAVE Life Sciences (NASDAQ:WVE) with a Buy and maintains $22 price...

 wave-life-sciences-announces-data-from-200-mg-single-and-multidose-and-400-mg-single-dose-cohorts-of-ongoing-phase-1b2a-restoraation-2-study-evaluating-wve-006-as-treatment-for-aatd

Achieved durable production of serum AAT protein at levels associated with a lower risk of AATD liver and lung diseases followi...

 canaccord-genuity-initiates-coverage-on-wave-life-sciences-with-buy-rating-announces-price-target-of-19

Canaccord Genuity analyst Whitney Ijem initiates coverage on WAVE Life Sciences (NASDAQ:WVE) with a Buy rating and announces...

 wells-fargo-maintains-overweight-on-wave-life-sciences-lowers-price-target-to-21

Wells Fargo analyst Tiago Fauth maintains WAVE Life Sciences (NASDAQ:WVE) with a Overweight and lowers the price target from...

 wave-life-sciences-q2-eps-031-misses-029-estimate-sales-8699m-miss-11245m-estimate

WAVE Life Sciences (NASDAQ:WVE) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION